Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma

Journal of Clinical Microbiology

Volumn 34, Issue 12, 1996, Pages 3016-3022

  Schuurman, Rob ^a   Descamps, Diane ^b   Weverling, Gerrit Jan ^c   Kaye, Steve ^d   Tijnagel, Jolanda ^a   Williams, Ian ^d   Van Leeuwen, Remko ^c   Tedder, Richard ^d   Boucher, Charles A B ^a   Brun Vezinet, Francoise ^b   Loveday, Clive ^e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b BICHAT HOSPITAL   (France)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCULATION; DIAGNOSTIC TEST; DNA DETERMINATION; HUMAN IMMUNODEFICIENCY VIRUS 1; MULTICENTER STUDY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; VIRUS INFECTION;

CHIRON; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 10544229339     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.12.3016-3022.1996     Document Type: Article

References (28)

1. Aboulker, J. P., and A. M. Swart. 1993. Preliminary analysis of the Concorde trial. Lancet 341:889-890. (Letter.)
2. Bruisten, S. M., M. H. Koppelman, M. T. Roos, A. E. Loeliger, P. Reiss, C. A. Boucher, and H. G. Huisman. 1993. Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments. AIDS 7(Suppl. 2):S15-S20.
3. Centers for Disease Control. 1987. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbid. Mortal. Weekly Rep. 36:S1-S5.
4. Coll, O., C. A. B. Boucher, C. Fortuny, B. M. de Tejada, Y. Canet, I. Caragol, J. Tijnagel, J. M. Bertran, and T. Espanol. Vertical HIV-1 transmission correlates with a high maternal viral load al delivery. J. Acquired Immune Defic. Syndr., in press.
5. Danner, S. A., A. Carr, J. M. Leonard, L. Lehman, F. Cudiol, J. Gonzalez, A. Rawentos, R. Rubio, E. Bouza, V. Pintado, A. G. Acuado, G. Garcia de Lomas, R. Delgado, J. C. Borleffs, A. Hsu, J. M. Valdes, C. A. B. Boucher, and D. A. Cooper. 1995. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. N. Engl. J. Med. 333:1528-1533.
6. + cells per cubic millimeter. N. Engl. J. Med. 333:1662-1669.
7. Finnley, D. J. 1978. Parallel line analysis, p. 69-104. In Statistical methods in biological assays. Charles Griffin and Company Ltd., London.
8. Fleiss, J. L. 1985. The design and analysis of clinical experiments. John Wiley & Sons, New York.
9. Fultz, T., J. Todd, S. Hamren, P. Sheridan, M. Collins, T. Yeghiazarian, D. Kern, D. Chernoff, and M. Urdea. 1995. Quantitaten of plasma HIV-1 RNA using an ultra-sensitive branched DNA (bDNA) assay, p. 93. In Program and Abstracts of the 2nd National Conference on Human Retroviruses.
10. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
11. Holodniy, M., D. A. Katzenstein, S. Sengupta, A. M. Wang, C. Casipit, D. H. Schwartz, M. Kimrad, E. Groves, and T. C. Merigan. 1991. Detection and quantification of human immunodeficiency virus RNA in patient scrum by use of the polymerase chain reaction. J. Infect. Dis. 163:862-866.
12. Katzenstein, T. L., C. Pedersen, C. Nielsen, J. D. Lundgren, P. H. Jakobsen, and J. Uerstoft. 1996. Longitudinal scrum HIV-RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome. AIDS 10:167-173.
13. Layne, S. P., M. J. Merges, M. Dembo, J. L. Spouge, S. R. Conley, J. P. Moore, J. L. Raina, H. Renz, H. R. Gelderblom, and P. L. Nara. 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189:695-714.
14. Loveday, C., and A. Hill. 1995. Prediction of progression to AIDS with serum HIV-1 RNA and CD4 count. Lancet 345:790-791. (Letter.)
15. Loveday, C., and R. Tedder. Personal communication.
16. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, Jr., J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
17. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. A rapid and simple PCR assay for quantification of HIV RNA: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
18. + lymphocyte counts and the risk of progression to AIDS. N. Engl. J. Med. 334:426-431.
19. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span. and viral generation time. Science 271:1582-1586.
20. Piatak, M., Jr., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High lewis of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
21. Scadden, D. T., Z. Wang, and J. E. Groopman. 1992. Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction. J. Infect. Dis. 165:1119-1123.
22. Schuurman, R., M. Nijhuis, R. van Leeuwen, P. Schipper, D. de Jong, P. Collis, S. A. Danner, J. Mulder, C. Loveday, C. Christopherson, et al. 1995. Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). J. Infect. Dis. 171:1411-1419.
23. Semple, M., C. Loveday, I. Weller, and R. Tedder. 1991. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J. Med. Virol. 35:38-45.
24. Urdea, M. S., J. C. Wilber, T. Yeghiazarian, J. A. Todd, D. G. Kern, S. J. Fong, D. Besemer, B. Hoo, P. J. Sheridan, R. Kokka, and et al. 1993. Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS 7(Suppl. 2):S4-S11.
25. van Gemen, B., T. Kievits, P. Nara, H. G. Huisman, S. Jurriaans, J. Goudsmit, and P. Lens. 1993. Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification. AIDS 7(Suppl. 2):S107-110.
26. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122.
27. Yen-Lieberman, B., D. Brambilla, B. Jackson, J. Bremer, R. Coombs, M. Cronin, S. Herman, D. Katzenstein, S. Leung, H. J. Lin, P. Palumbo, S. Rasheed, J. Todd, M. Vahey, and P. Reichelderfer. 1996. Evaluation of a quality assurance program for detection of human immunodeficiency virus type 1 plasma RNA by the AIDS Clinical Trials Group Virology Laboratories. J. Clin. Microbiol. 34:2695-2701.
28. Yerly, S., L. Kaiser, B. Mermillod, C. Baumberger, B. Hirschel, and L. Perrin. 1995. Response of HIV RNA to didanosine as a predictive marker of survival. AIDS 9:159-163.